Trending:
October 15, 2025, 01:47 PM - 5 min read
You could tell yourself “I’m proud of myself for getting stronger” or “It feels great to be more flexible now I’m moving more.” It’s OK not to respond when someone “compliments” you on weight loss, or even to choose not take on the labour of explaining why it’s harmful. On the days it feels challenging to speak up, be kind to yourself. Try saying something like, “Yeah, I’d rather not talk about my body” or “I promise my weight is the least interesting thing about me.”
Read moreJuly 3, 2025, 02:22 PM - 3 min read
Delhi High Court has asked the Drug Controller General of India to consult experts and relevant stakeholders in deciding a plea over drug combinations sold in the market for weight loss treatment.
Read moreDecember 23, 2024, 07:39 AM - 5 min read
Research shows that up to one-third of this weight loss is so-called “non-fat mass” – this includes muscle and bone mass. This also happens when someone goes on a diet, and after weight loss surgery.
Read moreNovember 15, 2024, 09:46 AM - 7 min read
The weight loss drug is extremely effective (people lose about 15% of their body weight in a year). It also appears to have many benefits beyond just weight loss.
Read moreOctober 10, 2024, 09:51 AM - 8 min read
The dietary supplement market has sought to cash in on the GLP-1 demand with pills, teas, extracts and all manner of other products that claim to produce similar effects as the brand names at a much lower price.
Read moreSeptember 27, 2024, 10:26 AM - 5 min read
The arrival of GLP-1 analogue drugs (such as Wegovy) marked a huge shift in the weight loss drug market. These drugs have been shown to lead to significant weight loss in users – as much as 15% or more of their body weight in clinical trials.
Read moreAugust 7, 2024, 10:58 AM - 2 min read
Originally developed as a treatment for type 2 diabetes, so-called “skinny jabs” containing the appetite-suppressant semaglutide are a relatively recent innovation.
Read moreJuly 6, 2024, 12:08 PM - 2 min read
Patients using diabetes and weight-loss drugs Ozempic and Wegovy might face a higher risk of developing a serious eye condition. This condition, called a stroke of the optic nerve or NAION, can lead to blindness, as per new research findings.
Read more